Echium oil: A valuable source of n-3 and n-6 fatty acids

OCL - Oleagineux Corps Gras Lipides

Volumn 15, Issue 4, 2008, Pages 252-256

  Mir, Miquel ^a  

^a Mevisa Site   (Spain)

Author keywords

Echium oil; Gamma linolenic; Omega 3; Omega 6; Stearidonic; Vegetable oil

Indexed keywords

BORAGINACEAE; ECHIUM; ECHIUM PLANTAGINEUM; OENOTHERA; PRIMULA;

EID: 57849108169     PISSN: 12588210     EISSN: None     Source Type: Journal    
DOI: 10.1051/ocl.2008.0203     Document Type: Review

References (49)

1. SIMOPOULOS AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002 ; 21(6) : 495-505.
2. CALDER PC. Polyunsaturated fatty acids and inflammation. Biochem Soc Transact 2005 ; 33 : 423-7.
3. DAS UN. Essential fatty acids : biochemistry, physiology and phatology. Biotechnol J 2006 ; 1 : 420-39.
4. SURETTE ME. The science behind dietary omega-3 fatty acids. Can Med Ass J 2008 ; 178(2) : 177-80.
5. US FDA HEART HEALTH CLAIM. Omega-3 fatty acids and Reduced Risk of Coronary Hearth Disease. Docket No 2003Q-0401 (9/8/2004).
6. AHRQ. Effects of Omega-3 Fatty acids on Cardiovascular Disease, Evidence Report/Technology Assessment No. 94. 2004. http://www.ahrq.gov/downloads/pub/ evidence/pdf/o3cardio/o3cardio.pdf.
7. BUCHER HC, HENGSTLER P, SCHINDLER C, MEIER G. n-3 Polyunsaturated fatty acids in coronary heart disease : a meta-analysis of randomized controlled trials. Am J Med 2002 ; 112 : 298-304.
8. BLOCK R, PEARSON TA. The cardiovascular implications of omega-3 fatty acids. Folia Cardiol 2006 ; 13 : 557-69.
9. MORI TA, WOODMAN RJ. The independent effects of eicosapentaenoic acid an docosahexaenoic acid on cardiosvascular risk factors in humans. Curr Opin Clin Nutr Metab Care 2006 ; 9(2) : 95-104.
10. HARRIS WS, MILLER M, TIGHE AP, DAVIDSON MH, SCHAEFER EJ. Omega-3 fatty acids and coronary heart disease risk : Clinical and mechanistic perspectives. Atherosclerosis 2008 ; 197(1) : 12-24.
11. AKABAS S, DECKELBAUM RJ. Summary of a workshop on n-3 fatty acids : current status of recommendations and future directions. Am J Clin Nutr 2006 ; 83(suppl) : 1536S-1538S.
12. FAN Y, CHAPKIN RS. Importance of dietary γ-linolenic acid in human health and nutrition. J Nutr 1998 ; 128 : 1411-4.
13. Gamma-linolenic acid (GLA). Altern Med Rev 2004 ; 9 : 70-8.
14. KAPOOR R, HUANG YS. Gamma linolenic acid ; an anti-inflammatory omega-6 fatty acid. Cur Pharm Biotechnol 2006 ; 7 : 531-4.
15. ARTERBURN LM, BAILEY E, OKEN H. Distribution, interconversion, and dose response of n-3 fatty acids in human. Am J Clin Nutr 2006 ; 83 : 1467S-1476S.
16. BURDGE G, CALDER PC. Conversion of α-linoleic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 2005 ; 45 : 581-97.
17. SERHAN CN, ARITA M, HONG S, GOTLINGER K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogeneous aspirin-triggered epimers. Lipids 2004 ; 39(11) : 1125-32.
18. JOHNSON MM, SWAN DD, SUREHE ME, ET AL. Dietary supplementation with γ-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr 1997 ; 127 : 1435-44.
19. BARHAM JB, EDENS MB, FONTEH AN, JOHNSON MM, EASTER L, CHILTON FH. Addition of Eicospentaenoic acid to γ-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr 2000 ; 130 : 1925-31.
20. VASQUEZ A. Reducing pain and inflammation naturally. Part II : New insights into fatty acid supplementation and its effects on eicosanoid production and genetic expression. J Counc Nutr Am Chiropr Ass 2005 ; 28(1) : 5-16.
21. LAIDLAW M, HOLUB B. Effects of supplementation with fish oil-derived n-3 fatty acids and γ-linolenic acid on circulating plasma lipids and fatty acid profiles in women. Am J Clin Nutr 2003 ; 77 : 37-42.
22. SUREHE M, KOUMENIS IL, EDENS MB, ET AL. Inhibition of leukotriene biosynthesis by a novel dietary fatty acid formulation in patients with atopic asthma : a randomized, placebo-controlled, parallel-group, prospective trial. Clin Nutr 2003 ; 25(3) : 972-9.
23. KOLETZKO B, ET AL. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy : review of current knowledge and consensus recommendations. J Perinat Med 2008 ; 36(1) : 5-14.
24. FRANCOIS CA, CONNOR SL, BOLEWICZ LC, CONNOR WE. Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk. Am J Clin Nutr 2003 ; 77 : 226-33.
25. SALA-VILA A, CASTELLOTE AI, RODRIGUEZ-PALMERO M, CAMPOY C, LÓPEZ-SABATER MC. Lipid composition in human breast milk form Granada (Spain) : changes during lactation. Nutrition 2005 ; 21 : 467-73.
26. SALA-VILA A, CASTELLOTE AI, CAMPOY C, RIVERO M, RODRIGUEZ-PALMERO M, LÓPEZ-SABATER MC. The source of long-chain PUFA in formula supplements does not affect the fatty acid composition of plasma lipids in full-term infants. J Nutr 2004 ; 134 : 868-73.
27. GEPPERT J, DEMMELMAIR H, HORNSTRA G, KOLETZKO B. Co-supplementation of healthy women with fish oil and evening primrose oil increases plasma docosahexaenoic acid, γ-linolenic acid and dihomo-γ-linolenic acid levels without reducing arachidonic acid concentrations. Br J Nutr 2008 ; 99(2) : 360-9.
28. rd annual meeting, Otawa, 2000.
29. SURETTE M, EDENS M, CHILTON F, TRAMPOSCH K. Dietary Echium oil increases plasma and neutrophil long-chain (n-3) fatty acids and lowers serum triacylglycerols in hypertriglyceridemic humans. J Nutr 2004 ; 134 : 1406-11.
30. ZHANG P, BOUDYGUINA E, WILSON MD, GEBRE AK, PARKS JS. Echium oil reduces plasma lipids and hepatic lipogenic gene expression in apoB100-only LDL receptor knockout mice. J Nutr Biochem 2007 ; (ahead of publication).
31. GUIL-GERRERO JL. Stearidonic acid (18 :4n-3) : Metabolism, nutritional importance, medical uses and natural sources. Eur J Lipid Sci Technol 2007 ; 109 : 1226-36.
32. GUICHARDANT M, TRAITLER H, SPIELMANN D, SPRECHER H, FINOT PA. Steridonic acid, an inhibitor of the 5-lipoxygenase pathway. A comparison with timnodonic acid and dihomo-γ-linoleic acid. Lipids 1983 ; 28(4) : 321-4.
33. KOCKMANN V, SPIELMANN D, TRAITLER H, LAGARDE M. Inhibitory effect of stearidonic acid (18 :4 n-3) on platelet aggregation and arachidonate oxygenation. Lipids 1989 ; 24 : 1004-7.
34. MILES EA, BANERJEE T, CALDER P. The influence of different combinations of γ-linolenic acid, stearidonic acid and EPA on the fatty acid composition of blood lipids and mononuclear cells in human volunteers. Prostagl Leukot Essent Fat Ac 2004 ; 70(6) : 529-38.
35. MILES EA, BANERJEE T, DOOPER M, M'RABET L, CRAUS Y, CALDER P. The influence of different combinations of γ-linolenic acid, stearidonic acid and EPA on immune function in healthy young male subjects. Br J Nutr 2004 ; 91 : 893-903.
36. HORIA E, WATKINS BA. Comparison of stearidonic acid and α-linolenic acid on PGE2 production and COX-2 protein levels in MDA-MB-231 breast cancer cell cultures. J Nutr Biochem 2005 ; 16(3) : 184-92.
37. PHIPPS JE, ENDERSON BL, JONES L, WHELAN J, KARLSTAD MD. Enteral nutrition with stearidonic acid increases incorporation of anti-inflammatory N-3 fatty acids in liver phospholipids in the rat. J Surg Res 2004 ; 121(2) : 330-1.
38. HARRIS WS, DIRIENZO MA, SANDS SA, GEORGE C, JONES PG, EAPEN AK. Stearidonic acid increases the reed blood cell and heart Eicosapentaenoic Acid content in Dogs. Lipids 2007 ; 42 : 325-33.
39. IAMES M, URSIN V, CLELAND L. Metabolism of stearidonic acid in human subjects : comparison with the methabolism of other n-3 fatty acids. Am J Clin Nutr 2003 ; 77 : 1140-5.
40. SIMON JA, HODGKINS ML, BROWNER WS, NEUHAUS JM, BERNERET JT, HULLEY SB. Serum fatty acids and the risk of coronary Heart disease. Am J Epidemiol 1995 ; 142(5) : 469-76.
41. RISSANEN T, VOUTILAINEN S, NYYSSÖNEN K, LAKKA TA, SALONEN JT. Fish-oil derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events : the Kuopio ischaemic heart disease risk factor study. Circulation 2000 ; 102(22) : 2677-9.
42. AKIBA S, MURATA T, KITATANI K, SATO T. Involvement of lipooxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation. Biol Pharm Bull 2000 ; 23(11) : 1293-7.
43. TSUJI M, SE-ITSU M, MORITA I. Docosapentanoic acid (22 :5, n-3) suppressed tube-forming activity in endothelial cells induced by vascular endothelial growth factor. Prostagl Leukot Essent Fat Ac 2003 ; 68 : 337-42.
44. KANAYASU-TOYODA T, MORITA I, MUROTA S. Docosapentaenoic acid (22 :5, n-3) an elongation metabolite of eicosapentaenoic acid (20 :5, n-3) is a potent stimulator of endothelial cell migration on pre-treatment in vitro. Prostagl Leukot Essent Fat Ac 1996 ; 54 : 319-25.
45. COUPLAND K, PACKER CE. US patent 6340485. Croda International Plc. 2002.
46. CHILTON FH, RUDEL LL, PARKS JS, ARM JP, SEEDS MC. Mechanisms by which botanical lipids affect inflammatory disorders. Am J Clin Nutr 2008 ; 87(2) : 498S-503S.
47. LETAWE C, BOONE M, PIERARD GE. Digital image analysis of the effect of topically applied linoleic acid on acne microcomedones. Clin Exp Dermatol 1998 ; 23 : 56-8.
48. ALESTAS T, GANCEVICIENE R, FIMMEL S, MÜLLER-DECKER K, ZOUBOULIS CC. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med 2006 ; 84 : 75-87.
49. ZOUBOULIS CC, ET AL. Treatment of inflammatory acne with an oral 5-lipoxygenase inhibitor. J Invest Dermatol 2001 ; 117 : 547.